Status:
COMPLETED
Effectiveness of Smartconsent in Improving Understanding of Informed Consent
Lead Sponsor:
Bioaraba Health Research Institute
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
The general objective of the study is to assess whether the new smartconsent tool improves patients' understanding of the intervention to be performed, compared to standard practice. A randomized cli...
Detailed Description
Male patients aged between 50 and 70 years, belonging to the Hospital Universitario Araba who are going to undergo PROSTATIC LASER ENUCLEATION, and who attend urology consultation between December 201...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients willing to receive information via tablet.
- Patients who know and can read.
- Exclusion Criteria:
- Not applicable
Exclusion
Key Trial Info
Start Date :
December 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04856943
Start Date
December 31 2021
End Date
December 31 2021
Last Update
July 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Imanol Merino
Vitoria-Gasteiz, Alava, Spain, 01003
2
Bioaraba Health Research Institute
Vitoria-Gasteiz, Alava, Spain, 01009